+

WO2001022864A3 - Sequences caracteristiques du cancer de la vessie - Google Patents

Sequences caracteristiques du cancer de la vessie Download PDF

Info

Publication number
WO2001022864A3
WO2001022864A3 PCT/US2000/041005 US0041005W WO0122864A3 WO 2001022864 A3 WO2001022864 A3 WO 2001022864A3 US 0041005 W US0041005 W US 0041005W WO 0122864 A3 WO0122864 A3 WO 0122864A3
Authority
WO
WIPO (PCT)
Prior art keywords
bladder cancer
expressed gene
indicative
patient
diagnosing
Prior art date
Application number
PCT/US2000/041005
Other languages
English (en)
Other versions
WO2001022864A2 (fr
WO2001022864A9 (fr
Inventor
Elena Feinstein
Orna Mor
Original Assignee
Quark Biotech Inc
Kohn Kenneth I
Elena Feinstein
Orna Mor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quark Biotech Inc, Kohn Kenneth I, Elena Feinstein, Orna Mor filed Critical Quark Biotech Inc
Priority to IL14879800A priority Critical patent/IL148798A0/xx
Priority to EP00977267A priority patent/EP1248855A4/fr
Priority to CA002385893A priority patent/CA2385893A1/fr
Priority to AU14926/01A priority patent/AU1492601A/en
Priority to US09/825,682 priority patent/US6998232B1/en
Publication of WO2001022864A2 publication Critical patent/WO2001022864A2/fr
Publication of WO2001022864A3 publication Critical patent/WO2001022864A3/fr
Publication of WO2001022864A9 publication Critical patent/WO2001022864A9/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte: sur un procédé de diagnostic du cancer de la vessie chez un patient par analyse d'un prélèvement de tissu pour y rechercher au moins un gène exprimé dont la présence est révélatrice du cancer de la vessie; sur une séquence de polynucléotide dont la présence est révélatrice du cancer de la vessie; sur un marqueur de cancer de la vessie; sur des procédés de diagnostic du cancer de la vessie par criblage pour détecter la présence d'au moins un gène exprimé dont la présence est révélatrice du cancer de la vessie; et sur des procédés de traitement et régulation des pathologies associées au cancer de la vessie par administration à un patient de doses à efficacité thérapeutique d'un ribozyme, d'un oligonucléotide antisens, ou d'un agoniste, agissant contre les séquences d'acides nucléiques de la présente invention.
PCT/US2000/041005 1999-09-27 2000-09-27 Sequences caracteristiques du cancer de la vessie WO2001022864A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IL14879800A IL148798A0 (en) 1999-09-27 2000-09-27 Sequences characteristic of bladder cancer
EP00977267A EP1248855A4 (fr) 1999-09-27 2000-09-27 Sequences caracteristiques du cancer de la vessie
CA002385893A CA2385893A1 (fr) 1999-09-27 2000-09-27 Sequences caracteristiques du cancer de la vessie
AU14926/01A AU1492601A (en) 1999-09-27 2000-09-27 Sequences characteristic of bladder cancer
US09/825,682 US6998232B1 (en) 1999-09-27 2001-04-04 Methods of diagnosing bladder cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15615399P 1999-09-27 1999-09-27
US60/156,153 1999-09-27

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/825,682 Continuation-In-Part US6998232B1 (en) 1999-09-27 2001-04-04 Methods of diagnosing bladder cancer

Publications (3)

Publication Number Publication Date
WO2001022864A2 WO2001022864A2 (fr) 2001-04-05
WO2001022864A3 true WO2001022864A3 (fr) 2001-11-01
WO2001022864A9 WO2001022864A9 (fr) 2002-12-12

Family

ID=22558336

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/041005 WO2001022864A2 (fr) 1999-09-27 2000-09-27 Sequences caracteristiques du cancer de la vessie

Country Status (5)

Country Link
EP (1) EP1248855A4 (fr)
AU (1) AU1492601A (fr)
CA (1) CA2385893A1 (fr)
IL (1) IL148798A0 (fr)
WO (1) WO2001022864A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998232B1 (en) 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
AU2002338431A1 (en) * 2001-04-04 2002-11-05 Quark Biotech, Inc. Sequence characteristics of bladder cancer
BR122020001099B1 (pt) 2004-07-23 2021-12-14 Pacific Edge Biotechnology Ltd Processos para a detecção de câncer de bexiga em indivíduos
EP2292796A1 (fr) * 2005-02-10 2011-03-09 Oncotherapy Science, Inc. Procédé de diagnostic de cancer de la vessie

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856136A (en) * 1996-07-03 1999-01-05 Incyte Pharmaceuticals, Inc. Human stem cell antigens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19818619A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Tumor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856136A (en) * 1996-07-03 1999-01-05 Incyte Pharmaceuticals, Inc. Human stem cell antigens

Also Published As

Publication number Publication date
EP1248855A2 (fr) 2002-10-16
IL148798A0 (en) 2002-09-12
AU1492601A (en) 2001-04-30
EP1248855A4 (fr) 2004-12-22
WO2001022864A2 (fr) 2001-04-05
WO2001022864A9 (fr) 2002-12-12
CA2385893A1 (fr) 2001-04-05

Similar Documents

Publication Publication Date Title
EP2157191A3 (fr) Procédé et acides nucléiques pour le traitement amélioré des troubles cellulaires proliférables du sein
EA200501772A1 (ru) Способы измерения экспрессии генов из фиксированного и залитого в парафин образца ткани
EP1953229A3 (fr) Gênes régulés du cancer du sein et du colôn métastatiques
WO2001068912A3 (fr) Diagnostic d'affections associees a des genes suppresseurs de tumeurs et a des oncogenes
WO2005059172A3 (fr) Procede et acides nucleiques permettant un traitement ameliore des troubles proliferatifs des cellules mammaires
WO2002002809A3 (fr) Diagnostic de troubles du comportement, de troubles neurologiques et de cancers
WO2003009814A3 (fr) Nouveaux genes, compositions, trousses et methodes d'identification, evaluation, prevention, et traitement du cancer de la prostate
WO1999022773A3 (fr) Sequences pour cibler les cellules metastatiques
EP1323728A3 (fr) Méthode pour préparer un standard diagnostique pour un motif de transcription génétique
WO2002044413A3 (fr) Procede permettant de mesurer l'expression du recepteur du facteur de croissance epidermique et du gene her2-neu et correlation de ces niveaux d'expression avec les taux de survie
WO2004047514A3 (fr) Procedes pour identifier des risques de cancer du sein, et traitements correspondants
AU2740100A (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
WO2004078035A3 (fr) Profiles d'expression pour le cancer du sein et methodes d'utilisation
WO2004005530A3 (fr) Compositions et techniques de traitement et de detection de cancers multiples
WO2002103042A3 (fr) Procede et acides nucleiques pour la differenciation des tumeurs de la prostate
WO2001022864A3 (fr) Sequences caracteristiques du cancer de la vessie
WO2004051269A3 (fr) Proteine de replication
WO2002064097A3 (fr) Expression du vegf-d dans le cancer du cerveau
WO2002040673A3 (fr) Compositions et methodes relatives a des genes et des proteines specifiques aux poumons
HK1042523A1 (zh) 青光眼和有關疾病的核酸、工具和其診斷、預後和治療的方法
WO2002086084A3 (fr) Caracteristiques sequentielles d'un cancer de la vessie
WO2001036674A3 (fr) Methodes de diagnostic
DE60131973T2 (de) Regulation der upa gen-expression durch methylierte nukleotide
WO2004048546A3 (fr) Procedes permettant de detecter le risque de cancer du sein et traitements pour ce dernier
WO2001049879A3 (fr) Expression genique et etats biologiques

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 09825682

Country of ref document: US

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 148798

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2385893

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 200202639

Country of ref document: ZA

Ref document number: 518141

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 14926/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000977267

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2000977267

Country of ref document: EP

AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2000977267

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载